| Date | Price Target | Rating | Analyst |
|---|
EFFECT - EUDA Health Holdings Ltd (0001847846) (Filer)
F-3/A - EUDA Health Holdings Ltd (0001847846) (Filer)
F-3 - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
SC 13G - EUDA Health Holdings Ltd (0001847846) (Subject)
MIAMI, Oct. 31, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces NRx Pharmaceuticals (NASDAQ:NRXP) will appear on the Emerging Growth Conference today in response to multiple requests and investor demand. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Jonathan Javitt, MD, MPH, Founder and Chairman will be discussing its first steps towards acquisition through its HOPE Therapeutics subsidiary of a national network of interventional psychiatry clinics focused on tr
MIAMI, Oct. 30, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Sponsor:QuoteMedia - Keep Investors Informed with Dynamic Plug and Play IR Solutions(844) [email protected]
MIAMI, Oct. 29, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 76th Emerging Growth Conference on October 30 & 31, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Sponsors:QuoteMedia - Keep Investors Informed with Dynamic Plug and Play IR Solutions(844) 485-8200Sales@Quote
New York, NY, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Diamond Equity Research, a leading equity research firm with a focus on small capitalization public companies has initiated coverage of EUDA Health Holdings Ltd. (NASDAQ:EUDA). The in-depth 30-page initiation report includes detailed information on the EUDA's business model, services, industry overview, valuation, management profile, and risks. The full research report is available here. EUDA Health Holdings Ltd. Initiation of Coverage Highlights from the report include: Strategic Acquisitions Expanding Product and Service Offerings: EUDA's growth strategy is supported by key acquisitions, i
MIAMI, Aug. 21, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 74th Emerging Growth Conference on August 21 – 22, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Sponsors:QuoteMedia - Keep Investors Informed with Dynamic Plug and Play IR Solutions(844) 485-8200Sales@QuoteM
MIAMI, Aug. 20, 2024 (GLOBE NEWSWIRE) -- EmergingGrowth.com a leading independent small cap media portal announces the schedule of the 74th Emerging Growth Conference on August 21 – 22, 2024. The Emerging Growth Conference identifies companies in a wide range of growth sectors, with strong management teams, innovative products & services, focused strategy, execution, and the overall potential for long-term growth. Register for the Conference here. Submit Questions for any of the presenting companies to: [email protected] For updates, follow us on Twitter Sponsors:QuoteMedia - Keep Investors Info
Singapore, May 08, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, proudly announces the successful completion of its acquisition of CK Health Plus Sdn Bhd ("CK Health") today. This strategic move marks an expansion of EUDA's presence in Malaysia and underscores its commitment to revolutionizing the healthcare landscape in the region. CK Health is a direct seller of holistic wellness consumer products in Malaysia, committed to delivering high-quality products that promote holistic well-being. With this acquisition, EUD
SINGAPORE, May 06, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem, today announced that it will acquire CK Health Plus Sdn Bhd ("CK Health"), a direct seller of holistic wellness consumer products in Malaysia. Under the terms of the acquisition agreement, EUDA has agreed to acquire the entire issued capital of CK Health for an aggregate share consideration of 10 million newly issued ordinary shares of the Company, valued at US$15 million. The acquisition is expected to close on 8th May 2024, subject to customary closin
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited ("EUDA" and the "Company") received a written notice from Nasdaq on January 9, 2024 indicating that the Company had failed to maintain a minimum market value of listed securities of $35 million over the previous 30 consecutive business days (the "MVLS Requirement") as required by the Nasdaq Listing Rule 5550(b)(2). On January 16, 2024, the Company received a written notice from Nasdaq stating that the Company's Market Value of Listed Securities has been $35 million or greater for ten consecutive business days from January 2 to January 16, 2024, and therefore the Company has regained complia
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- EUDA Health Holdings Limited ("EUDA" and the "Company") received a written notice (the "MVLS Notice") from Listing Qualifications Department of The Nasdaq Stock Market ("Nasdaq") on January 9, 2024 indicating that the Company had failed to maintain a Minimum Market Value of Listed Securities ("MVLS") of $35 million over the previous 30 consecutive business days as required by the Nasdaq Listing Rule 5550(b)(2). The MVLS Notice has no immediate effect on the listing of the Company's securities on Nasdaq and the Company has been provided a period of 180 calendar days from the date of the MVLS Notice, or until July 8, 2024, in which to regain com
Gainers CNS Pharma (NASDAQ:CNSP) stock rose 109.5% to $2.64 during Thursday's pre-market session. The company's market cap stands at $2.2 million. Autonomix Medical (NASDAQ:AMIX) stock moved upwards by 37.23% to $1.29. The company's market cap stands at $24.3 million. Inspire Veterinary (NASDAQ:IVP) shares moved upwards by 21.37% to $1.59. The company's market cap stands at $1.5 million. Salarius Pharmaceuticals (NASDAQ:SLRX) stock increased by 13.63% to $2.5. The market value of their outstanding shares is at $1.4 million. Absci (NASDAQ:ABSI) stock increased by 13.46% to $3.37. The company's market cap stands at $381.0 million. Traws Pharma (NASDAQ:TRAW) stock increased by 12.32% to $
Gainers Clover Health Investments (NASDAQ:CLOV) shares increased by 14.9% to $0.85 during Tuesday's after-market session. The market value of their outstanding shares is at $421.4 million. The company's, Q1 earnings came out today. Inogen (NASDAQ:INGN) shares increased by 13.97% to $8.32. The market value of their outstanding shares is at $195.9 million. As per the press release, Q1 earnings came out today. Nektar Therapeutics (NASDAQ:NKTR) shares rose 11.92% to $1.69. The market value of their outstanding shares is at $310.3 million. Agape ATP (NASDAQ:ATPC) stock increased by 8.33% to $0.26. The company's market cap stands at $20.0 million. EUDA Health Holdings (NASDAQ:EUDA) stock incr
Gainers Cellectis S.A. (NASDAQ:CLLS) shares jumped 136% to $2.2799. Cellectis reported strategic collaboration and investment agreements with AstraZeneca. Cellectis also presented pre-clinical data on multi-armored allogeneic MUC1-CAR T-cells targeting triple-negative breast cancer at the Society for Immunotherapy of Cancer 38th Annual Meeting. Patriot Transportation Holding, Inc. (NASDAQ:PATI) climbed 104.8% to $15.73. Patriot Transportation announced an agreement under which United Petroleum Transports will acquire all of the outstanding shares of Patriot common stock for $16.26 per share in cash. Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) gained 33% to $2.2780. Aldeyra Therapeutics e
Gainers SciSparc Ltd. (NASDAQ:SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment. Cardio Diagnostics Holdings, Inc. (NASDAQ:CDIO) gained 53.1% to $0.3264 after the company received an Innovation Technology contract from Vizient for its novel AI-driven precision heart disease tests. Verve Therapeutics, Inc. (NASDAQ:VERV) jumped 27% to $11.95. Eli Lilly said it will acquire rights under Beam Therapeutics’ amended collaboration and license agreement with Verve, including rights to co-develop and co-commercialize Ver
EUDA Health Holdings Limited ("EUDA" or the "Company") (NASDAQ:EUDA), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering enhanced outcomes through personalized healthcare, today announced that it has signed a letter of intent dated October 4, 2023, with respect to the proposed merger with TheoremRx Inc. ("TheoremRx"), a private U.S.-based company focused on the development of new treatments with safe administration, low toxicity, and a high potential for polypharmacy usage to benefit patients suffering from cancer and women's health conditions. The two parties have agreed to a 30-day exclusivity
Gainers Tenon Medical (NASDAQ:TNON) shares increased by 54.2% to $0.22 during Tuesday's pre-market session. The market value of their outstanding shares is at $5.0 million. Cosmos Health (NASDAQ:COSM) shares moved upwards by 40.4% to $1.39. The market value of their outstanding shares is at $18.1 million. Avalo Therapeutics (NASDAQ:AVTX) shares increased by 39.45% to $0.12. The company's market cap stands at $2.3 million. Lyra Therapeutics (NASDAQ:LYRA) shares increased by 20.32% to $5.15. The company's market cap stands at $255.1 million. MoonLake (NASDAQ:MLTX) stock increased by 18.77% to $62.5. The company's market cap stands at $3.3 billion. T2 Biosystems (NASDAQ:TTOO) shares rose
Gainers Fulcrum Therapeutics (NASDAQ:FULC) stock rose 43.4% to $5.62 during Tuesday's regular session. Fulcrum Therapeutics's stock is trading at a volume of 68.5 million shares as of 13:31 EST. This is 9987.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $347.4 million. Regencell Bioscience (NASDAQ:RGC) shares increased by 28.57% to $18.0. The market value of their outstanding shares is at $234.2 million. CNS Pharma (NASDAQ:CNSP) stock rose 24.81% to $1.52. As of 13:31 EST, this security is trading at a volume of 670.2K shares, making up 152.5% of its average full-day volume over the last 100 days. The market value of their out